Mark Hlatky, MD
Publication Details
-
The effect of bivalirudin on costs and outcomes of treatment of ST-segment elevation myocardial infarction.
Am Heart J. 2011; (3): 494-500.e2
Bivalirudin is commonly used during percutaneous coronary intervention (PCI) rather than unfractionated heparin. The higher cost of bivalirudin may be offset if it reduces costly bleeding complications and/or length of stay. We sought to assess the effect of using bivalirudin on the costs of care among patients with ST-segment elevation myocardial infarction (STEMI) undergoing PCI.
Help